Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases

N6-methyladenosine (m6A) is a post-transcriptional RNA modification and one of the most abundant types of RNA chemical modifications. m6A functions as a molecular switch and is involved in a range of biomedical aspects, including cardiovascular diseases, the central nervous system, and cancers. Conc...

Full description

Bibliographic Details
Main Authors: Yazhen You, Yundong Fu, Mingjie Huang, Dandan Shen, Bing Zhao, Hongmin Liu, Yichao Zheng, Lihua Huang
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/10/5815
_version_ 1797499103093981184
author Yazhen You
Yundong Fu
Mingjie Huang
Dandan Shen
Bing Zhao
Hongmin Liu
Yichao Zheng
Lihua Huang
author_facet Yazhen You
Yundong Fu
Mingjie Huang
Dandan Shen
Bing Zhao
Hongmin Liu
Yichao Zheng
Lihua Huang
author_sort Yazhen You
collection DOAJ
description N6-methyladenosine (m6A) is a post-transcriptional RNA modification and one of the most abundant types of RNA chemical modifications. m6A functions as a molecular switch and is involved in a range of biomedical aspects, including cardiovascular diseases, the central nervous system, and cancers. Conceptually, m6A methylation can be dynamically and reversibly modulated by RNA methylation regulatory proteins, resulting in diverse fates of mRNAs. This review focuses on m6A demethylases fat-mass- and obesity-associated protein (FTO) and alkB homolog 5 (ALKBH5), which especially erase m6A modification from target mRNAs. Recent advances have highlighted that FTO and ALKBH5 play an oncogenic role in various cancers, such as acute myeloid leukemias (AML), glioblastoma, and breast cancer. Moreover, studies in vitro and in <i>mouse</i> models confirmed that FTO-specific inhibitors exhibited anti-tumor effects in several cancers. Accumulating evidence has suggested the possibility of FTO and ALKBH5 as therapeutic targets for specific diseases. In this review, we aim to illustrate the structural properties of these two m6A demethylases and the development of their specific inhibitors. Additionally, this review will summarize the biological functions of these two m6A demethylases in various types of cancers and other human diseases.
first_indexed 2024-03-10T03:42:39Z
format Article
id doaj.art-8ee68289653348cbbc0ee7a3b4c0ee1f
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T03:42:39Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-8ee68289653348cbbc0ee7a3b4c0ee1f2023-11-23T11:28:56ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-05-012310581510.3390/ijms23105815Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human DiseasesYazhen You0Yundong Fu1Mingjie Huang2Dandan Shen3Bing Zhao4Hongmin Liu5Yichao Zheng6Lihua Huang7Green Catalysis Center, College of Chemistry, Zhengzhou University, Zhengzhou 450001, ChinaGreen Catalysis Center, College of Chemistry, Zhengzhou University, Zhengzhou 450001, ChinaGreen Catalysis Center, College of Chemistry, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, ChinaGreen Catalysis Center, College of Chemistry, Zhengzhou University, Zhengzhou 450001, ChinaN6-methyladenosine (m6A) is a post-transcriptional RNA modification and one of the most abundant types of RNA chemical modifications. m6A functions as a molecular switch and is involved in a range of biomedical aspects, including cardiovascular diseases, the central nervous system, and cancers. Conceptually, m6A methylation can be dynamically and reversibly modulated by RNA methylation regulatory proteins, resulting in diverse fates of mRNAs. This review focuses on m6A demethylases fat-mass- and obesity-associated protein (FTO) and alkB homolog 5 (ALKBH5), which especially erase m6A modification from target mRNAs. Recent advances have highlighted that FTO and ALKBH5 play an oncogenic role in various cancers, such as acute myeloid leukemias (AML), glioblastoma, and breast cancer. Moreover, studies in vitro and in <i>mouse</i> models confirmed that FTO-specific inhibitors exhibited anti-tumor effects in several cancers. Accumulating evidence has suggested the possibility of FTO and ALKBH5 as therapeutic targets for specific diseases. In this review, we aim to illustrate the structural properties of these two m6A demethylases and the development of their specific inhibitors. Additionally, this review will summarize the biological functions of these two m6A demethylases in various types of cancers and other human diseases.https://www.mdpi.com/1422-0067/23/10/5815m6A demethylasesFTOAKBH5human diseasesinhibitors
spellingShingle Yazhen You
Yundong Fu
Mingjie Huang
Dandan Shen
Bing Zhao
Hongmin Liu
Yichao Zheng
Lihua Huang
Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases
International Journal of Molecular Sciences
m6A demethylases
FTO
AKBH5
human diseases
inhibitors
title Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases
title_full Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases
title_fullStr Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases
title_full_unstemmed Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases
title_short Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases
title_sort recent advances of m6a demethylases inhibitors and their biological functions in human diseases
topic m6A demethylases
FTO
AKBH5
human diseases
inhibitors
url https://www.mdpi.com/1422-0067/23/10/5815
work_keys_str_mv AT yazhenyou recentadvancesofm6ademethylasesinhibitorsandtheirbiologicalfunctionsinhumandiseases
AT yundongfu recentadvancesofm6ademethylasesinhibitorsandtheirbiologicalfunctionsinhumandiseases
AT mingjiehuang recentadvancesofm6ademethylasesinhibitorsandtheirbiologicalfunctionsinhumandiseases
AT dandanshen recentadvancesofm6ademethylasesinhibitorsandtheirbiologicalfunctionsinhumandiseases
AT bingzhao recentadvancesofm6ademethylasesinhibitorsandtheirbiologicalfunctionsinhumandiseases
AT hongminliu recentadvancesofm6ademethylasesinhibitorsandtheirbiologicalfunctionsinhumandiseases
AT yichaozheng recentadvancesofm6ademethylasesinhibitorsandtheirbiologicalfunctionsinhumandiseases
AT lihuahuang recentadvancesofm6ademethylasesinhibitorsandtheirbiologicalfunctionsinhumandiseases